✦ LIBER ✦

BTK: 22 novel and 25 recurrent mutations in European patients with X-linked agammaglobulinemia

✍ Scribed by Maurilia Fiorini; Roberta Franceschini; Annarosa Soresina; Richard-Fabian Schumacher; Alberto G. Ugazio; Paolo Rossi; Alessandro Plebani; Luigi D. Notarangelo

Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 60 KB
Volume: 23
Category: Article
ISSN: 1059-7794
DOI: 10.1002/humu.9219

No coin nor oath required. For personal study only.

✦ Synopsis

Communicated by

📜 SIMILAR VOLUMES

Identification of mutations of Bruton's

Identification of mutations of Bruton's tyrosine kinase gene (BTK) in Brazilian patients with X-linked agammaglobulinemia

✍ Sergio Massayuki Tani; Yue Wang; Hirokazu Kanegane; Takeshi Futatani; Jorge Pint 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB

Mutations in the Bruton tyrosine kinase (BTK) gene are responsible for X-linked agammaglobulinemia (XLA), which is characterized by recurrent bacterial infections, profound hypogammaglobulinemia, and decreased numbers of mature B cells in the peripheral blood. We evaluated 17 male Brazilian patients

BTK mutations in patients with X-linked

BTK mutations in patients with X-linked agammaglobulinemia: Lack of correlation between presence of peripheral B lymphocytes and specific mutations

✍ Luan Tao; Mark Boyd; Greg Gonye; Barbara Malone; Jerrold Schwaber 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 2 views

Identification of the bruton tyrosine ki

Identification of the bruton tyrosine kinase (BTK) gene mutations in 20 Australian families with X-linked agammaglobulinemia (XLA)

✍ Marija Velickovic; Madhuri L. Prasad; Susan A. Weston; Elizabeth M. Benson 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 33 KB

X-linked agammaglobulinemia (XLA) is an immunodeficiency caused by mutations in the Bruton tyrosine kinase (BTK) gene. Twenty Australian patients with an XLA phenotype, from 15 unrelated families, were found to have 14 mutations. Five of the mutations were previously described c.83G>A (p.R28H), c.86

Bruton tyrosine kinase gene mutations in

Bruton tyrosine kinase gene mutations in Turkish patients with presumed X-linked agammaglobulinemia

✍ Yue Wang; Hirokazu Kanegane; Ozden Sanal; Fügen Ersoy; Ilhan Tezcan; Takeshi Fut 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 25 KB

Communicated by Mark H. Paalman X-linked agammglobulinemia (XLA) is a ptototypical humoral immunodeficiency caused by mutations in the gene coding for Bruton tyrosine kinase (BTK). The genetic defect in XLA impairs early B cell development resulting in marked reduction of mature B cells in the blood

Novel insertions of Bruton tyrosine kina

Novel insertions of Bruton tyrosine kinase in patients with X-linked agammaglobulinemia

✍ Michael P. Okoh; Leena Kainulainen; Kaarina Heiskanen; M. Nizam Isa; Kim Varming 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB

Mutations in the gene encoding Bruton tyrosine kinase (BTK) result in X-linked agammaglobulinemia (XLA), an immunodeficiency of antibody defect. By using base excision sequence scanning method (BESS) followed by direct sequencing we found in seven unrelated families with a classical XLA phenotype va

Novel JARID1C/SMCX mutations in patients

Novel JARID1C/SMCX mutations in patients with X-linked mental retardation

✍ Andreas Tzschach; Steffen Lenzner; Bettina Moser; Richard Reinhardt; Jamel Chell 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

X-linked mental retardation (XLMR) is a heterogeneous disorder that affects approximately 2 in 1000 males. JARID1C/SMCX is relatively new among the known XLMR genes, and seven different mutations have been identified previously in this gene [Jensen LR et al., Am. J. Hum. Genet. 76:227-236, 2005]. He